Source: FinanzNachrichten

Q-linea: Q-Linea AB: Q-linea announces preliminary outcome of the rights issue

Q-linea AB (publ) ("Q-linea" or the "Company") (Nasdaq Stockholm: QLINEA) announces the preliminary outcome of the Company's rights issue of approximately SEK 225 (the "Rights Issue"), for which th...

Read full article »

Q-linea's Competitors | Q-linea's News | Q-linea's Financials

Followers on Owler

195

Annual Revenue

$100K-5.0M

Employees

100-250

CEO

Jonas Jarvius

CEO Approval Rating

90/100

Q-linea is a Sweden-based medical device company that develops protein and nucleic acid analysis instruments, and systems for the healthcare industry.